SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscaler is trending as investors react to a post-earnings sell-off, where despite the company beating revenue and earnings expectations, the stock plummeted on concerns regarding forward growth deceleration and management's conservative guidance. Community members are actively debating whether this sharp correction is an overreaction or a structural reset, with many discussing strategies for catching the potential dip versus waiting for technical stability.

Digital Turbine, Inc. is a mobile growth platform that offers solutions for advertisers, publishers, carriers, and device original equipment manufacturers (OEMs). The firm operates through the On Device Solutions (ODS) and App Growth Platform (AGP) segments. The ODS segment generates revenue from the delivery of mobile application media or content to end users with solutions for all participants in the mobile application ecosystem that want to connect with end users and consumers who hold the device. This includes mobile carriers and device OEMs that participate in the app economy, app publishers and developers, and brands and advertising agencies. The AGP segment provides platforms that allow mobile app publishers and developers to monetize their monthly active users via display, native, and video advertising. The company was founded on November 6, 1998 and is headquartered in Austin, TX.

Digital Turbine Inc

Digital Turbine is experiencing significant market interest and price appreciation following a strong quarterly earnings beat and positive forward-looking guidance for fiscal year 2027. Investors are actively discussing the company's turnaround progress, debt reduction efforts, and recent strategic partnerships as catalysts for a potential short squeeze against heavily shorted positions.

Sidus Space, Inc. is a space-as-a-service company. The firm focuses on commercial satellite design, manufacture, launch planning, mission operations and in-orbit support, and data collection with a vision to demonstrate space operations for new technologies, and deliver data and predictive analytics to both domestic and global customers. The company was founded by Carol M. Craig on July 17, 2012 and is headquartered in Merritt Island, FL.

Sidus Space Inc - Ordinary Shares - Class A

Sidus Space is trending as investors aggressively build positions in aerospace stocks ahead of the anticipated SpaceX IPO, with the community actively tracking its inclusion in the Russell 3000 and ongoing defense contract momentum. Sentiment remains highly bullish among long-term holders who are ignoring short-term volatility, while traders continue to focus on key technical breakouts and potential institutional accumulation.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending as investors aggressively position themselves ahead of upcoming earnings, fueled by optimism surrounding custom AI chip demand and ongoing data center infrastructure growth. The community is actively debating the stock's significant price extension and institutional ownership, with bullish sentiment focused on long-term AI-driven potential while bears remain concerned about overvaluation and potential volatility following the earnings event.

Keel Infrastructure Corp. engages in building artificial intelligence focused data centers and energy assets. It focuses on infrastructure and energy required to support high-performance computing and artificial intelligence workloads. The company was founded on April 1, 2026 and is headquartered in New York, NY.

Keel Infrastructure Corp.

Keel Infrastructure Corp

Keel Infrastructure Corp is trending as investors aggressively accumulate shares, fueled by anticipation of multiple upcoming infrastructure lease announcements and potential inclusion in the Russell 3000. Community sentiment remains highly bullish, with many viewing the stock as a strategic play on the growing bottleneck for AI power and data center capacity.

Momentus, Inc. engages in the provision of in-space infrastructure services. It offers space transportation and in-orbit servicing. The company was founded by Mikhail Kokorich in 2017 and is headquartered in Santa Jose, CA.

Momentus Inc - Ordinary Shares - Class A

Momentus Inc. is trending as traders speculate on potential spillover effects from the upcoming SpaceX IPO, driving significant volume and volatility in the aerospace and satellite services sector. Community sentiment is sharply divided between bullish investors betting on fundamental re-rating and government contract catalysts, and skeptical bears warning of potential dilution risks and the stock's historical tendency for rapid reversals.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is trending as investors react to a wider-than-expected quarterly loss alongside reports of increased operational spending, even as the community actively debates the commercial growth of their lead fibromyalgia treatment. Long-term shareholders are expressing significant frustration over ongoing share dilution and management's capital allocation, while a subset of the community continues to closely track prescription volume trends and payer coverage updates as potential catalysts for a turnaround.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific stock is under pressure following a guidance cut during an investor presentation, despite strong fundamentals and ongoing support from share buyback programs. The community remains divided, with some investors viewing the sell-off as a manipulative "short attack" on a healthy company, while others are cautioning against the risks of potential litigation and slowing growth.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is surging after reaching a historic trillion-dollar market cap, fueled by an aggressive UBS price target hike and intensifying optimism surrounding the company's role as a critical AI infrastructure and memory supplier. While bulls are celebrating the massive year-to-date rally and potential for further gains, the community remains intensely divided between those betting on continued parabolic growth and others cautioning that the stock has become dangerously overheated.

Tema ETF Trust - Tema Space Innovators ETF

Tema Space Innovators ETF ($NASA) is seeing significant investor attention as the most accessible pure-play vehicle for retail exposure to the upcoming SpaceX IPO. The community is actively debating the fund's direct exposure through special purpose vehicles, with many holding it as a long-term strategic play to capture the broader expansion of the space economy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TGTX Stock Rises 29% in 3 Months: Here's What You Should Know

TG Therapeutics gains on strong Briumvi sales growth, higher 2026 revenue guidance and advancing late-stage studies in RMS.

TGTX Q1 Earnings Miss, Sales Rise Y/Y, Stock Up on Raised 2026 View

TG Therapeutics misses Q1 earnings estimates, but strong Briumvi sales drive y/y revenues. Shares rise as the company raises 2026 revenue outlook.

TG Therapeutics (NASDAQ:TGTX) Reaches New 1-Year High  - Time to Buy?

TG Therapeutics (NASDAQ:TGTX) Reaches New 1-Year High - Here's Why...

TGTX Stock Hits Fresh 52-Week High – Here’s Why Retail Is Bullish Despite Q1 Earnings Miss

Equity

The company increased its U.S. sales forecast for Briumvi to $885 - $900 million, up from the earlier $825 - $850 million range

TG Therapeutics (TGTX) Q1 Earnings Lag Estimates

TG Therapeutics (TGTX) delivered earnings and revenue surprises of -26.88% and +2.81%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

TG Therapeutics Inc. Q1 Profit Climbs

(RTTNews) - TG Therapeutics Inc. (TGTX.OB) released earnings for its first quarter that Increased, from last year...

Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS platform to develop in vivo gene editing therapies for high unmet need diseases, today reported financial results for the first quarter ended March 31, 2026, and provided a...

Pictet Asset Management Holding SA Trims Stock Position in TG Therapeutics, Inc. $TGTX

Pictet Asset Management Holding SA lowered its stake in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 9.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 1,461,048 shares of the biopharmaceutical company's stock after selling 148,503 sha...

TG Therapeutics, Inc. (NASDAQ:TGTX) Given Average Rating of "Moderate Buy" by Analysts

TG Therapeutics, Inc. (NASDAQ:TGTX - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the six ratings firms that are covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, three have given a buy reco...

Fortrea Holdings Inc. (FTRE) Reports Next Week: Wall Street Expects Earnings Growth

Fortrea Holdings Inc. (FTRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. For more information, visit www.tgtherapeutics.com, and follow us on X (formerly Twitter) @TGTherapeutics and on LinkedIn.

Current Price	$39.94
Prev Close	$39.73
Open	$40.16
Dividend Yield	0.00%
50-Day Moving Average	$35.64
Beta	0.99
Avg. Volume	1.75M
PE Ratio	13.85

52-Week High	$44.65
52-Week Low	$25.28
Market Capitalization	$6.08B
EPS (Annual)	$2.77
Price to Book	10.43
Revenue Per Employee	$1.54M

TGTX
TG Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest TGTX News

TGTXTG Therapeutics Inc